Literature DB >> 30379102

Plasma syndecan-1 in hemodialysis patients associates with survival and lower markers of volume status.

Josephine Koch1, Nienke M A Idzerda1, Wendy Dam1, Solmaz Assa1,2, Casper F M Franssen1, Jacob van den Born1.   

Abstract

Syndecan-1, a transmembrane heparan sulfate proteoglycan, associates with renal and cardiovascular functioning. We earlier reported syndecan-1 to be involved in renal tubular regeneration. We now examined plasma values of syndecan-1 in a hemodialysis cohort and its association with volume and inflammatory and endothelial markers in addition to outcome. Eighty-four prevalent hemodialysis patients were evaluated for their plasma syndecan-1 levels by ELISA before the start of hemodialysis, as well as 60, 180, and 240 min after start of dialysis. Patients were divided into sex-stratified tertiles based on predialysis plasma syndecan-1 levels. We studied the association between plasma levels of syndecan-1 and volume, inflammation, and endothelial markers and its association with cardiovascular events and all-cause mortality using Kaplan-Meier curves and Cox regression analyses with adjustments for gender, age, diabetes, and dialysis vintage. Predialysis syndecan-1 levels were twofold higher in men compared with women ( P = 0.0003). Patients in the highest predialysis plasma syndecan-1 tertile had a significantly higher ultrafiltration rate ( P = 0.034) and lower plasma values of BNP ( P = 0.019), pro-ANP ( P = 0.024), and endothelin ( P < 0.0001) compared with the two lower predialysis syndecan-1 tertiles. No significant associations with inflammatory markers were found. Cox regression analysis showed that patients in the highest syndecan-1 tertile had significantly less cardiovascular events and better survival compared with the lowest syndecan-1 tertile ( P = 0.02 and P = 0.005, respectively). In hemodialysis patients, higher plasma syndecan-1 levels were associated with lower concentrations of BNP, pro-ANP, and endothelin and with better patient survival. This may suggest that control of volume status in hemodialysis patients allows an adaptive tissue regenerative response as reflected by higher plasma syndecan-1 levels.

Entities:  

Keywords:  hemodialysis; inflammation; syndecan-1; ultrafiltration

Mesh:

Substances:

Year:  2018        PMID: 30379102     DOI: 10.1152/ajprenal.00252.2018

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  2 in total

Review 1.  Ways and Means of Cellular Reconditioning for Kidney Regeneration.

Authors:  Shinya Ishiko; Michael S Goligorsky
Journal:  Am J Nephrol       Date:  2022-03-08       Impact factor: 4.605

2.  Baseline endothelial-related biomarkers in hemodialysis patients and risk of developing severe SARS-Cov-2 infection.

Authors:  Cícero Abdon Malheiro Gomes; Bianca Matos de Carvalho Borges; Lucas Oliveira Lemos; Camilla Maroni Marques Freire de Medeiros; Paula Roberta de Lima; Gdayllon Cavalcante Meneses; Alice Costa Martins; Candice Torres de Melo Bezerra Cavalcante; Marcelo Borges Cavalcante; Alexandre Braga Libório
Journal:  J Nephrol       Date:  2021-07-19       Impact factor: 3.902

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.